Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
actiTENS vs Level 2 Analgesics in Knee Osteoarthritis
NCT03902340Unknown
- Sponsor
- Sublimed
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Sublimed. Primary endpoints: Pain Intensity on Numerical Scale at 3 months and Occurrence of Adverse Events at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT03902340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03902340.